未登录

Z

Zubida M. Al-Majdoub

University of Manchester

H指数:18

被引数:1,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories

将生理信息整合到经鼻给药至脑的药代动力学模型中的挑战与机遇：当前状态与未来发展趋势综述

Molecular Pharmaceutics

IF4.5

2025-06-170

PRE

Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitis

林格列汀（BI-1356）对FOXO3a核定位的调控揭示了慢性溃疡性结肠炎的一个新的治疗靶点

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2025-06-010

OAAI

Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients

常染色体显性多囊肾病患者的肾脏药物转运体和药物代谢酶蛋白表达变化

Clinical Pharmacology & Therapeutics

IF5.5

2025-05-150

OAAI

Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2025-03-010

OAAI

The quest to define cancer-specific systems parameters for personalized dosing in oncology

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2025-03-010

PRE

Transporter expressions as part of required scaling factor to support in vitro in vivo extrapolation for blood-brain barrier drug permeability

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2025-01-010

OA

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof-of-Concept Application of Liquid Biopsy in Renal Impairment

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-05-133

OAAI

Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver

MOLECULAR OMICS

IF2.4

2024-01-010

OA

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2023-03-016

OA

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2022-10-0111

OAAI

Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2022-03-2825

OAAI

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

IF3.7

2022-01-1314

OAAI

Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-12-0317

OAAI

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2021-09-0720

OAAI

Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin

IF3

2020-12-0323

OAAI

Effects of Gentamicin on the Proteomes of Aerobic and Oxygen-Limited Escherichia coli

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2013-03-2911

PREAI